ID   RenCa
AC   CVCL_2174
SY   Renca; RENCA; Renal Carcinoma
DR   ATCC; CRL-2947
DR   BCRJ; 0346
DR   BioGRID_ORCS_Cell_line; 1259
DR   BioSample; SAMN11397652
DR   CCRID; 6101MOU-CERC000110
DR   ChEMBL-Cells; CHEMBL3307979
DR   ChEMBL-Targets; CHEMBL612568
DR   CLS; 400321
DR   KCLB; 80022
DR   PubChem_Cell_line; CVCL_2174
DR   Wikidata; Q54949734
RX   PubMed=3486710;
RX   PubMed=31220119;
CC   Doubling time: ~24 hours (ATCC=CRL-2947).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 16,17,18
ST   Mouse STR 1-2: 16,18
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,17
ST   Mouse STR 18-3: 18,20
ST   Mouse STR 19-2: 13,14
ST   Mouse STR 2-1: 15,16,17
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 23.2,25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR X-1: 25
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 20
//
RX   PubMed=3486710;
RA   Salup R.R., Wiltrout R.H.;
RT   "Adjuvant immunotherapy of established murine renal cancer by
RT   interleukin 2-stimulated cytotoxic lymphocytes.";
RL   Cancer Res. 46:3358-3363(1986).
//
RX   PubMed=31220119; DOI=10.1371/journal.pone.0218412;
RA   Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S.,
RA   Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H.,
RA   Li J.-L., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B.,
RA   Natoli M., Bauer B.A., Gollin S.M., Lewis D.W., Reid Y.A.;
RT   "Interlaboratory study to validate a STR profiling method for
RT   intraspecies identification of mouse cell lines.";
RL   PLoS ONE 14:E0218412-E0218412(2019).
//